Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Following a tolerance study, double-blind placebo controlled trials were conducted to determine the prophylactic effect of zinc gluconate lozenges on rhinovirus challenge and, in a third study, their therapeutic efficacy when given at the start of colds caused by virus inoculation was tested. In the prophylaxis study a total of 57 volunteers received lozenges of either zinc gluconate (23 mg) (29 volunteers) or matched placebo (28 volunteers) every 2 h while awake during a period of four and a half days. They were challenged with 102 tissue culture infecting dose (TCID50) of human rhinovirus 2 (HRV-2) on the second day of medication, and were monitored daily for symptoms and signs of colds and laboratory evidence of infection. Zinc reduced the total mean clinical score from 8.2 in the placebo group to 5.7 and the reduction of the mean clinical score was statistically significant on the second day after virus challenge. In the therapeutic study 69 volunteers were inoculated with 102 TCID50 of HRV-2 and those who developed cold symptoms were randomly allocated to receive either zinc gluconate lozenges (six volunteers) or matched placebo lozenges (six volunteers) every two hours they were awake for six days. Treatment of colds with zinc reduced the mean daily clinical score and this was statistically significant on the fourth and fifth day of medication. Similarly, medication also reduced the mean daily nasal secretion weight and total tissue count and these reductions were statistically significant on days two and six for nasal secretion weights and days four to six of medication for tissue counts when compared with placebo. There were also statistically significant reductions in the mean total nasal secretion weights and total tissue counts. Zinc, however, had no significant effect on the rate or amount of virus excreted by volunteers. We conclude that zinc gluconate lozenges are reasonably well tolerated and that they have a significant effect on the signs and symptoms of colds caused by rhinoviruses, although the mechanism of action remains obscure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study
Eby, G. A., Davis, D. R., & Halcomb, W. W. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.20 · Cited by 217 · cited 2×
“Recently, however, Eby et al.”
Cited by
Sazawal, S., Black, R. E., Jalla, S., Mazumdar, S., Sinha, A., & Bhan, M. K. (1998) · Pediatrics · doi:10.1542/peds.102.1.1 · Cited by 543
ZINC AND THE RISK FOR INFECTIOUS DISEASE
Walker, C. F., & Black, R. E. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073054 · Cited by 491
Immune-enhancing role of vitamin C and zinc and effect on clinical conditions
Wintergerst, E. S., Maggini, S., & Hornig, D. H. (2006) · Annals of Nutrition and Metabolism · doi:10.1159/000090495 · Cited by 418
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
Wessels, I., Rolles, B., & Rink, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01712 · Cited by 336
Zinc-Altered Immune Function and Cytokine Production
Rink, L., & Kirchner, H. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.5.1407s · Cited by 271
Metadata
- Authors
- Al-Nakib, W., Higgins, P. G., Barrow, I., Batstone, G., & Tyrrell, D. A. J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1987
- Volume
- 20
- Issue
- 6
- Pages
- 893-901
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2072060208
- Cited by
- 107
- References
- 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. https://app.cochat.ai/papers/10.1093/jac/20.6.893
- The paper
- Al-Nakib, W., Higgins, P. G., Barrow, I., Batstone, G., & Tyrrell, D. A. J. (1987). Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/20.6.893
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.